Date:  September 16th, 2026

Location: Noto’s Old World Italian Dining | 6600 28th St SE, Grand Rapids, MI 49546

Time: Registration begins at 6:30 PM | Dinner & presentation begin at 7:00 PM

Topic: Managing Hypertrophic Cardiomyopathy in Feline Patients

PROGRAM OVERVIEW

Introducing the first FDA conditionally approved once-weekly drug for the management of ventricular hypertrophy in cats with subclinical hypertrophic cardiomyopathy (HCM).

This first-in-class drug is now available to manage progressive left ventricular (LV) hypertrophy in cats with subclinical HCM. Now you have a reason to screen to intervene and manage subclinical HCM in your feline patients. We will outline the pathophysiology of HCM and review the indications for Felycin-CA1.

Note:

• This event is limited to 40 attendees
• This event is RACE Approved
• This meeting is open to member veterinarians at this time.

Speaker:

Lillian Rogers, BVMS

Cat Friendly Veterinarian Certified

Feline Heart Health Certified